175 related articles for article (PubMed ID: 8975754)
21. A probabilistic framework for non-cancer risk assessment.
Chen JJ; Moon H; Kodell RL
Regul Toxicol Pharmacol; 2007 Jun; 48(1):45-50. PubMed ID: 17166641
[TBL] [Abstract][Full Text] [Related]
22. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
Bokkers BG; Slob W
Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
[TBL] [Abstract][Full Text] [Related]
23. Neurotoxicity modeling for risk assessment.
Kodell RL; Chen JJ; Gaylor DW
Regul Toxicol Pharmacol; 1995 Aug; 22(1):24-9. PubMed ID: 7494899
[TBL] [Abstract][Full Text] [Related]
24. Comparing experimental designs for benchmark dose calculations for continuous endpoints.
Kuljus K; von Rosen D; Sand S; Victorin K
Risk Anal; 2006 Aug; 26(4):1031-43. PubMed ID: 16948695
[TBL] [Abstract][Full Text] [Related]
25. Precision of estimates of an ADI (or TDI or PTWI).
Speijers GJ
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S87-93. PubMed ID: 10597619
[TBL] [Abstract][Full Text] [Related]
26. The use of benchmark dose methodology with acute inhalation lethality data.
Fowles JR; Alexeeff GV; Dodge D
Regul Toxicol Pharmacol; 1999 Jun; 29(3):262-78. PubMed ID: 10388612
[TBL] [Abstract][Full Text] [Related]
27. Health assessment of phosgene: approaches for derivation of reference concentration.
Gift JS; McGaughy R; Singh DV; Sonawane B
Regul Toxicol Pharmacol; 2008 Jun; 51(1):98-107. PubMed ID: 18440110
[TBL] [Abstract][Full Text] [Related]
28. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
[TBL] [Abstract][Full Text] [Related]
29. Model uncertainty and risk estimation for experimental studies of quantal responses.
Bailer AJ; Noble RB; Wheeler MW
Risk Anal; 2005 Apr; 25(2):291-9. PubMed ID: 15876205
[TBL] [Abstract][Full Text] [Related]
30. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
31. Effects of exposure imprecision on estimation of the benchmark dose.
Budtz-Jørgensen E; Keiding N; Grandjean P
Risk Anal; 2004 Dec; 24(6):1689-96. PubMed ID: 15660622
[TBL] [Abstract][Full Text] [Related]
32. Principles of risk assessment for determining the safety of chemicals: recent assessment of residual solvents in drugs and di(2-ethylhexyl) phthalate.
Hasegawa R; Koizumi M; Hirose A
Congenit Anom (Kyoto); 2004 Jun; 44(2):51-9. PubMed ID: 15198717
[TBL] [Abstract][Full Text] [Related]
33. Development of an occupational exposure limit for n-propylbromide using benchmark dose methods.
Stelljes ME; Wood RR
Regul Toxicol Pharmacol; 2004 Oct; 40(2):136-50. PubMed ID: 15450717
[TBL] [Abstract][Full Text] [Related]
34. Benchmark dose approaches in chemical health risk assessment in relation to number and distress of laboratory animals.
Oberg M
Regul Toxicol Pharmacol; 2010 Dec; 58(3):451-4. PubMed ID: 20800084
[TBL] [Abstract][Full Text] [Related]
35. Dose-response modeling of in vivo genotoxicity data for use in risk assessment: some approaches illustrated by an analysis of acrylamide.
Allen B; Zeiger E; Lawrence G; Friedman M; Shipp A
Regul Toxicol Pharmacol; 2005 Feb; 41(1):6-27. PubMed ID: 15649824
[TBL] [Abstract][Full Text] [Related]
36. The use of myocardial and testicular end points as a basis for estimating a proposed tolerable daily intake for sodium monofluoroacetate (1080).
Foronda NM; Fowles J; Smith N; Taylor M; Temple W; Darlington C
Regul Toxicol Pharmacol; 2007 Feb; 47(1):29-36. PubMed ID: 17030370
[TBL] [Abstract][Full Text] [Related]
37. Calculation of benchmark doses for reproductive and developmental toxicity observed after exposure to isopropanol.
Allen B; Gentry R; Shipp A; Van Landingham C
Regul Toxicol Pharmacol; 1998 Aug; 28(1):38-44. PubMed ID: 9784431
[TBL] [Abstract][Full Text] [Related]
38. Dose-response relationship of teratogenicity and prenatal-toxic risk estimation of 6-mercaptopurine riboside in mice.
Platzek T; Bochert G
Teratog Carcinog Mutagen; 1996; 16(3):169-81. PubMed ID: 8983119
[TBL] [Abstract][Full Text] [Related]
39. Risk assessment of thujone in foods and medicines containing sage and wormwood--evidence for a need of regulatory changes?
Lachenmeier DW; Uebelacker M
Regul Toxicol Pharmacol; 2010 Dec; 58(3):437-43. PubMed ID: 20727933
[TBL] [Abstract][Full Text] [Related]
40. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
Sanner T; Dybing E; Willems MI; Kroese ED
Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
